Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
REVOLUTION Medicines
18 followers
Halozyme Therapeutics
10 followers
Owkin
9 followers
4D Molecular Therapeutics
8 followers
BillionToOne
7 followers
Immunovant
7 followers
Tectonic Therapeutic
5 followers
Stemline Therapeutics
4 followers
Biocytogen
4 followers
Vor Biopharma
4 followers
ADMA Biologics
3 followers
Biosynth
3 followers